Informed decision making with prostate cancer screening options: ‘WHY’?

The focus of prostate cancer prevention research has switched FROM advocating for screening TO advocating for informed decision-making among men. In other words, we are now trying to inform men of their options and advocate that they have an open and honest dialogue with their physician on their treatment options. Joseph-Williams et al (2010) looks...Continue reading

Medicare Evidence Development and Coverage Advisory Committee Recommends Medicare Reimbursement of Provenge

Yesterday, the Medicare Evidence Development and Coverage Advisory Committee’s (MEDCAC) vote on a number of questions amounted to a recommendation to the Centers for Medicare and Medicaid Services (CMS) to cover Provenge, a therapeutic vaccine for men with advanced prostate cancer.  While the recommendation was not overwhelmingly enthusiastic, Provenge clears one hurdle on its way...Continue reading

Scroll to top